0000021076false6/30Q32024http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://www.clorox.com/20240331#OtherExpenseIncomeNethttp://www.clorox.com/20240331#OtherExpenseIncomeNethttp://www.clorox.com/20240331#OtherExpenseIncomeNethttp://www.clorox.com/20240331#OtherExpenseIncomeNethttp://www.clorox.com/20240331#OtherExpenseIncomeNet00000210762023-07-012024-03-3100000210762024-04-16xbrli:shares00000210762024-01-012024-03-31iso4217:USD00000210762023-01-012023-03-3100000210762022-07-012023-03-31iso4217:USDxbrli:shares00000210762024-03-3100000210762023-06-3000000210762022-06-3000000210762023-03-310000021076us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberclx:ArgentinaBusinessMember2024-03-20clx:productionPlant0000021076us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberclx:ArgentinaBusinessMember2023-07-012024-03-310000021076us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberclx:ArgentinaBusinessMember2024-01-012024-03-310000021076us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberclx:ArgentinaBusinessMember2023-01-012023-03-310000021076us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberclx:ArgentinaBusinessMember2022-07-012023-03-310000021076clx:CyberattackMember2024-01-012024-03-310000021076clx:CyberattackMember2023-07-012024-03-310000021076clx:CostOfGoodsAndServicesSoldMemberclx:CyberattackMember2024-01-012024-03-310000021076clx:CostOfGoodsAndServicesSoldMemberclx:CyberattackMember2023-07-012024-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMemberclx:CyberattackMember2024-01-012024-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMemberclx:CyberattackMember2023-07-012024-03-310000021076srt:MaximumMember2024-03-3100000210762022-07-012023-06-300000021076srt:ScenarioForecastMembersrt:MinimumMember2024-06-300000021076srt:ScenarioForecastMembersrt:MaximumMember2024-06-300000021076srt:ScenarioForecastMembersrt:MinimumMemberus-gaap:EmployeeSeveranceMember2024-06-300000021076srt:ScenarioForecastMemberus-gaap:EmployeeSeveranceMembersrt:MaximumMember2024-06-300000021076clx:CostOfGoodsAndServicesSoldMember2022-07-012023-03-310000021076clx:CostOfGoodsAndServicesSoldMember2024-01-012024-03-310000021076clx:CostOfGoodsAndServicesSoldMember2023-07-012024-03-310000021076clx:CostOfGoodsAndServicesSoldMember2023-01-012023-03-310000021076clx:CostOfGoodsAndServicesSoldMember2022-07-012024-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012024-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-03-310000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012024-03-310000021076us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012024-03-310000021076us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310000021076us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012024-03-310000021076us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012023-03-310000021076us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310000021076clx:OtherExpenseIncomeNetMember2023-07-012024-03-310000021076clx:OtherExpenseIncomeNetMember2022-07-012023-03-310000021076clx:OtherExpenseIncomeNetMember2024-01-012024-03-310000021076clx:OtherExpenseIncomeNetMember2023-01-012023-03-310000021076clx:OtherExpenseIncomeNetMember2022-07-012024-03-3100000210762022-07-012024-03-310000021076us-gaap:EmployeeSeveranceMember2023-06-300000021076us-gaap:OtherRestructuringMember2023-06-300000021076us-gaap:EmployeeSeveranceMember2023-07-012024-03-310000021076us-gaap:OtherRestructuringMember2023-07-012024-03-310000021076us-gaap:EmployeeSeveranceMember2024-03-310000021076us-gaap:OtherRestructuringMember2024-03-310000021076clx:VitaminsMineralsAndSupplementsReportingUnitMember2023-01-012023-03-310000021076clx:InternationalReportingUnitMember2023-01-012023-03-310000021076clx:TotalCommodityPurchaseDerivativeContractsMember2023-07-012024-03-310000021076clx:TotalCommodityPurchaseDerivativeContractsMember2024-03-310000021076clx:TotalCommodityPurchaseDerivativeContractsMember2023-06-300000021076clx:PurchasesofInventoryMemberus-gaap:ForeignExchangeContractMember2024-03-310000021076clx:PurchasesofInventoryMemberus-gaap:ForeignExchangeContractMember2023-06-300000021076us-gaap:CommodityContractMember2024-01-012024-03-310000021076us-gaap:CommodityContractMember2023-01-012023-03-310000021076us-gaap:CommodityContractMember2023-07-012024-03-310000021076us-gaap:CommodityContractMember2022-07-012023-03-310000021076us-gaap:ForeignExchangeContractMember2024-01-012024-03-310000021076us-gaap:ForeignExchangeContractMember2023-01-012023-03-310000021076us-gaap:ForeignExchangeContractMember2023-07-012024-03-310000021076us-gaap:ForeignExchangeContractMember2022-07-012023-03-310000021076us-gaap:InterestRateContractMember2024-01-012024-03-310000021076us-gaap:InterestRateContractMember2023-01-012023-03-310000021076us-gaap:InterestRateContractMember2023-07-012024-03-310000021076us-gaap:InterestRateContractMember2022-07-012023-03-310000021076us-gaap:CommodityContractMember2024-03-310000021076us-gaap:CommodityContractMember2023-06-300000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommodityContractMember2024-03-310000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommodityContractMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000021076us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MoneyMarketFundsMember2024-03-310000021076us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MoneyMarketFundsMember2023-06-300000021076us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2024-03-310000021076us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2023-06-300000021076us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000021076us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000021076us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-3000000210762023-12-142023-12-1400000210762023-12-140000021076clx:HealthAndWellnessMember2023-12-142023-12-14clx:extensionOptionxbrli:pure0000021076us-gaap:CommonStockMember2022-12-310000021076us-gaap:AdditionalPaidInCapitalMember2022-12-310000021076us-gaap:RetainedEarningsMember2022-12-310000021076us-gaap:TreasuryStockCommonMember2022-12-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000021076us-gaap:NoncontrollingInterestMember2022-12-3100000210762022-12-310000021076us-gaap:RetainedEarningsMember2023-01-012023-03-310000021076us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000021076us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000021076us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000021076us-gaap:CommonStockMember2023-03-310000021076us-gaap:AdditionalPaidInCapitalMember2023-03-310000021076us-gaap:RetainedEarningsMember2023-03-310000021076us-gaap:TreasuryStockCommonMember2023-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000021076us-gaap:NoncontrollingInterestMember2023-03-310000021076us-gaap:CommonStockMember2023-12-310000021076us-gaap:AdditionalPaidInCapitalMember2023-12-310000021076us-gaap:RetainedEarningsMember2023-12-310000021076us-gaap:TreasuryStockCommonMember2023-12-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000021076us-gaap:NoncontrollingInterestMember2023-12-3100000210762023-12-310000021076us-gaap:RetainedEarningsMember2024-01-012024-03-310000021076us-gaap:NoncontrollingInterestMember2024-01-012024-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000021076us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000021076us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000021076us-gaap:CommonStockMember2024-03-310000021076us-gaap:AdditionalPaidInCapitalMember2024-03-310000021076us-gaap:RetainedEarningsMember2024-03-310000021076us-gaap:TreasuryStockCommonMember2024-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000021076us-gaap:NoncontrollingInterestMember2024-03-310000021076us-gaap:CommonStockMember2022-06-300000021076us-gaap:AdditionalPaidInCapitalMember2022-06-300000021076us-gaap:RetainedEarningsMember2022-06-300000021076us-gaap:TreasuryStockCommonMember2022-06-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000021076us-gaap:NoncontrollingInterestMember2022-06-300000021076us-gaap:RetainedEarningsMember2022-07-012023-03-310000021076us-gaap:NoncontrollingInterestMember2022-07-012023-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012023-03-310000021076us-gaap:AdditionalPaidInCapitalMember2022-07-012023-03-310000021076us-gaap:TreasuryStockCommonMember2022-07-012023-03-310000021076us-gaap:CommonStockMember2023-06-300000021076us-gaap:AdditionalPaidInCapitalMember2023-06-300000021076us-gaap:RetainedEarningsMember2023-06-300000021076us-gaap:TreasuryStockCommonMember2023-06-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000021076us-gaap:NoncontrollingInterestMember2023-06-300000021076us-gaap:RetainedEarningsMember2023-07-012024-03-310000021076us-gaap:NoncontrollingInterestMember2023-07-012024-03-310000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012024-03-310000021076us-gaap:AdditionalPaidInCapitalMember2023-07-012024-03-310000021076us-gaap:TreasuryStockCommonMember2023-07-012024-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012023-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012023-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012023-03-310000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012024-03-310000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012024-03-310000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012024-03-310000021076country:USclx:RetirementIncomeMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310000021076country:USclx:RetirementIncomeMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000021076country:USclx:RetirementIncomeMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012024-03-310000021076country:USclx:RetirementIncomeMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012023-03-310000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2024-01-012024-03-310000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2022-07-012023-03-310000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2023-07-012024-03-310000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2023-01-012023-03-310000021076clx:AlamedaCountyCaliforniaMatterMember2024-03-310000021076clx:AlamedaCountyCaliforniaMatterMember2023-06-300000021076clx:AlamedaCountyCaliforniaMatterMember2023-07-012024-03-310000021076clx:DickinsonCountyMichiganMatterMember2024-03-310000021076clx:DickinsonCountyMichiganMatterMember2023-06-300000021076clx:DickinsonCountyMichiganMatterMember2023-07-012024-03-31clx:reportableSegment0000021076clx:HealthAndWellnessMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:HealthAndWellnessMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000021076us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000021076us-gaap:CorporateNonSegmentMember2023-07-012024-03-310000021076us-gaap:CorporateNonSegmentMember2022-07-012023-03-310000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2024-01-012024-03-310000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2023-01-012023-03-310000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2023-07-012024-03-310000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2022-07-012023-03-310000021076clx:HealthAndWellnessMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HealthAndWellnessMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:HouseholdMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HouseholdMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:LifestyleMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:LifestyleMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:InternationalMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:InternationalMemberclx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310000021076clx:CyberattackMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2023-07-012024-03-310000021076clx:CyberattackMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000021076clx:CyberattackMemberus-gaap:ProductConcentrationRiskMember2023-07-012024-03-310000021076clx:HealthAndWellnessMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HealthAndWellnessMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:HealthAndWellnessMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:HealthAndWellnessMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:HealthAndWellnessMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012024-03-310000021076clx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012024-03-310000021076clx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012024-03-310000021076clx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000021076clx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000021076clx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2023-07-012024-03-310000021076clx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000021076clx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMember2022-07-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2023-07-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2022-07-012023-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2022-07-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMember2023-07-012024-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMember2022-07-012023-03-310000021076clx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:ProductConcentrationRiskMember2022-07-012024-03-310000021076clx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:CleaningMemberclx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:CleaningMemberclx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:CleaningMemberclx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:CleaningMemberclx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:ProfessionalProductsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:ProfessionalProductsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:ProfessionalProductsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:ProfessionalProductsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HealthAndWellnessMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:CatLitterMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:CatLitterMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:CatLitterMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:CatLitterMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HouseholdMemberclx:GrillingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HouseholdMemberclx:GrillingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HouseholdMemberclx:GrillingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HouseholdMemberclx:GrillingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:HouseholdMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:LifestyleMemberclx:FoodProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:LifestyleMemberclx:FoodProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:LifestyleMemberclx:FoodProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:LifestyleMemberclx:FoodProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:NaturalPersonalCareMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:NaturalPersonalCareMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:NaturalPersonalCareMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:NaturalPersonalCareMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:WaterFiltrationMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:WaterFiltrationMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:WaterFiltrationMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:WaterFiltrationMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:LifestyleMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076clx:InternationalMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076clx:InternationalMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076clx:InternationalMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076clx:InternationalMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-01-012024-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-01-012023-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-07-012024-03-310000021076us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-07-012023-03-31



















10-Q
 (Mark One)☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


March 31, 2024


☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





1-07151





THE CLOROX COMPANY


Delaware31-0595760(State or other jurisdiction of(I.R.S. Employer Identification No.)incorporation or organization)


1221 Broadway Oakland California 94612-1888





510 271-7000


(Former name, former address and former fiscal year, if changed since last report)___________________Securities registered pursuant to Section 12(b) of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock - $1.00 par valueCLXNew York Stock Exchange





Yes





Yes





Large accelerated filer☑Accelerated filer☐Non-accelerated filer☐Smaller Reporting Company☐Emerging Growth Company☐











☑





124,188,188







---










PagePART I - FINANCIAL INFORMATION3Item 1. Financial Statements3Condensed Consolidated Statements of Earnings and Comprehensive Income3Condensed Consolidated Balance Sheets4Condensed Consolidated Statements of Cash Flows5Notes to Condensed Consolidated Financial Statements6Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations21Item 3. Quantitative and Qualitative Disclosures About Market Risk37Item 4. Controls and Procedures37PART II - OTHER INFORMATION38Item 1.A. Risk Factors38Item 2. Unregistered Sales of Equity Securities and Use of Proceeds38Item 5. Other Information38Item 6. Exhibits39







---





















Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Net sales$1,814$1,915$5,190$5,370Cost of products sold1,0481,1153,0263,324Gross profit7668002,1642,046Selling and administrative expenses301311899854Advertising costs215206566523Research and development costs323593100Loss on divestiture240—240—Pension settlement charge——171—Goodwill, trademark and other asset impairments—445—445Interest expense22246969Other (income) expense, net(2)24354Earnings (losses) before income taxes(42)(245)1231Income tax expense (benefit)8(36)5221Net earnings (losses)(50)(209)71(20)Less: Net earnings attributable to noncontrolling interests1277Net earnings (losses) attributable to Clorox$(51)$(211)$64$(27)Net earnings (losses) per share attributable to CloroxBasic net earnings (losses) per share$(0.41)$(1.71)$0.52$(0.22)Diluted net earnings (losses) per share$(0.41)$(1.71)$0.52$(0.22)Weighted average shares outstanding (in thousands)Basic124,249123,649124,133123,512Diluted124,249123,649124,721123,512Comprehensive income (loss)$154$(205)$409$(39)Less: Total comprehensive income attributable to noncontrolling interests1277Total comprehensive income (loss) attributable to Clorox$153$(207)$402$(46)













---










3/31/20246/30/2023(Unaudited)ASSETSCurrent assetsCash and cash equivalents$219$367Receivables, net673688Inventories, net674696Prepaid expenses and other current assets9577Total current assets1,6611,828Property, plant and equipment, net of accumulated depreciation and amortizationof $2,800 and $2,705, respectively1,2921,345Operating lease right-of-use assets379346Goodwill1,2291,252Trademarks, net539543Other intangible assets, net149169Other assets556462Total assets$5,805$5,945LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilitiesNotes and loans payable$111$50Current operating lease liabilities8287Accounts payable and accrued liabilities1,6531,659Income taxes payable—121Total current liabilities1,8461,917Long-term debt2,4802,477Long-term operating lease liabilities347310Other liabilities853825Deferred income taxes2428Total liabilities5,5505,557Commitments and contingenciesStockholders’ equityPreferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding——Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2024 and June 30, 2023; and 124,186,844 and 123,820,022 shares outstanding as of March 31, 2024 and June 30, 2023, respectively131131Additional paid-in capital1,2701,245Retained earnings34583Treasury stock, at cost: 6,554,617 and 6,921,439 shares as of March 31, 2024and June 30, 2023, respectively(1,189)(1,246)Accumulated other comprehensive net (loss) income(155)(493)Total Clorox stockholders’ equity91220Noncontrolling interests164168Total stockholders’ equity255388Total liabilities and stockholders’ equity$5,805$5,945













---










Nine months ended3/31/20243/31/2023Operating activities:Net earnings (losses)$71$(20)Adjustments to reconcile net earnings (losses) to net cash provided by operations:Depreciation and amortization176174Stock-based compensation5560Deferred income taxes(126)(122)Loss on divestiture238—Pension settlement charge171—Goodwill, trademark and other asset impairments—445Other1834Changes in:Receivables, net(16)(1)Inventories, net2013Prepaid expenses and other current assets12(15)Accounts payable and accrued liabilities(120)78Operating lease right-of-use assets and liabilities, net—2Income taxes payable / prepaid(144)80Net cash provided by operations355728Investing activities:Capital expenditures(131)(144)Proceeds from divestiture, net of cash divested17—Other202Net cash used for investing activities(94)(142)Financing activities:Notes and loans payable, net61(99)Cash dividends paid to Clorox stockholders(446)(437)Issuance of common stock for employee stock plans and other310Net cash used for financing activities(382)(526)Effect of exchange rate changes on cash, cash equivalents and restricted cash(26)—Net increase (decrease) in cash, cash equivalents and restricted cash(147)60Cash, cash equivalents and restricted cash:Beginning of period368186End of period$221$246
















---
















SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES































DIVESTITURE OF ARGENTINA BUSINESS


two


240 223








---




DivestitureWorking capital, net$31Property, plant and equipment, net18Goodwill(1)16Other assets3Other liabilities(3)Net assets divested$65








Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Net sales$43$46$123$127







CYBERATTACK








8 57 The following table summarizes the recognition of costs in the condensed consolidated statements of earnings and comprehensive income:





Three months endedNine months ended3/31/20243/31/2024Costs of products sold$1$21Selling and administrative expenses736Total$8$57


no







---




SUPPLY CHAIN FINANCING PROGRAM


120


All outstanding amounts related to suppliers participating in the SCF program are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets and the associated payments are included in operating activities within the condensed consolidated statements of cash flows. As of March 31, 2024 and June 30, 2023, the amount due to suppliers participating in the SCF program and included in Accounts payable and accrued liabilities was $208 and $220, respectively.




RESTRUCTURING AND RELATED COSTS





60 30 40 10 20





Three months endedNine months endedInception to date ended3/31/20243/31/20233/31/20243/31/20233/31/2024Costs of products sold$—$—$—$(1)$(3)Selling and administrative expenses5681120Research and development————(1)Other (income) expense, net:Employee-related costs51553457Total, net$10$21$13$44$73














---




Employee-Related CostsOtherTotalAccrual Balance as of June 30, 2023$23$5$28Charges5914Cash payments(20)(9)(29)Accrual Balance as of March 31, 2024$8$5$13




INVENTORIES, NET


3/31/20246/30/2023Finished goods$588$595Raw materials and packaging179182Work in process128LIFO allowances(104)(87)Total inventories, net$675$698Less: Non-current inventories, net(1)12Total current inventories, net$674$696







GOODWILL, TRADEMARKS AND OTHER ASSETS IMPAIRMENTS





no











Impairment ChargesVMS reporting unitInternational reporting unitTotalGoodwill$306$—$306Trademarks, net12712139Total$433$12$445


83










---




FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS











2


44 41





2


38 51





3




















---




Gains (losses) recognized in Other comprehensive (loss) incomeThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Commodity purchase derivative contracts$—$(4)$(5)$(6)Foreign exchange derivative contracts2111Total$2$(3)$(4)$(5)





Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earningsGains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earningsThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Commodity purchase derivative contractsCost of products sold$(2)$—$(4)$7Foreign exchange derivative contractsCost of products sold———1Interest rate derivative contractsInterest expense441010Total$2$4$6$18


10





0 1





1 0











---

























The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:


3/31/20246/30/2023Balance sheetclassificationFair valuehierarchylevelCarryingAmountEstimatedFairValueCarryingAmountEstimatedFairValueAssetsCommodity purchase options contractsPrepaid expenses and other current assets1$—$—$2$2Commodity purchase swaps contractsPrepaid expenses and other current assets211——Foreign exchange forward contractsPrepaid expenses and other current assets211——$2$2$2$2LiabilitiesCommodity purchase futures contractsAccounts payable and accrued liabilities1————Commodity purchase swaps contractsAccounts payable and accrued liabilities2——11$—$—$1$1





---




3/31/20246/30/2023Balance sheetclassificationFair valuehierarchylevelCarryingAmountEstimatedFairValueCarryingAmountEstimatedFairValueAssetsInterest-bearing investments, including money market fundsCash and cashequivalents(1)1$76$76$243$243Time depositsCash and cashequivalents(1)2131399Trust assets for nonqualified deferred compensation plansOther assets1151151129129$240$240$381$381LiabilitiesNotes and loans payableNotes and loans payable(2)2$111$111$50$50Current maturities of long-term debt and Long-term debtCurrent maturities of long-term debt and Long-termdebt(3)22,4802,3562,4772,327$2,591$2,467$2,527$2,377













OTHER (INCOME) EXPENSE, NET





Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Amortization of trademarks and other intangible assets$7$8$22$22Trust investment (gains) losses, net(8)(7)(18)(8)Net periodic benefit cost141112Foreign exchange transaction (gains) losses, net(1)14247Income from equity investees(1)(1)(3)(3)Interest income(4)(4)(21)(9)Restructuring costs(2)515534Gain on sale-leaseback transaction(3)——(16)—Other(3)5(1)(1)Total$(2)$24$3$54








19 3 16 8 two
  5







---




INCOME TAXES


18.6 41.9 14.7 1813.5


314 61




NET EARNINGS (LOSSES) PER SHARE (EPS)


Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Basic124,249123,649124,133123,512Dilutive effect of stock options and other——588—Diluted124,249123,649124,721123,512Antidilutive stock options and other4,7584,9532,7204,953





no




COMPREHENSIVE INCOME (LOSS)





Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Net earnings (losses)$(50)$(209)$71$(20)Other comprehensive (loss) income, net of tax:Foreign currency translation adjustments20610212(1)Net unrealized gains (losses) on derivatives(1)(7)(10)(21)Pension and postretirement benefit adjustments(1)11363Total other comprehensive (loss) income, net of tax2044338(19)Comprehensive income (loss)154(205)409(39)Less: Total comprehensive income attributable to noncontrolling interests1277Total comprehensive income (loss) attributable to Clorox$153$(207)$402$(46)







---




STOCKHOLDERS
 ’EQUITY





Three months ended March 31(Dollars in millions except per share data; shares in thousands)Common stockAdditional paid-in capitalRetained earningsTreasury stockAccumulatedothercomprehensivenet (loss) incomeNoncontrolling interestsTotal stockholders’ equityAmountSharesAmountSharesBalance as of December 31, 2022$131130,741$1,207$782$(1,297)(7,263)$(502)$170$491Net earnings (losses)———(211)———2(209)Other comprehensive (loss) income——————4—4Dividends to Clorox stockholders ($1.18 per share declared)———(147)————(147)Dividends to noncontrolling interests———————(3)(3)Stock-based compensation——29—————29Other employee stock plan activities——(4)(9)20133——7Balance as of March 31, 2023$131130,741$1,232$415$(1,277)(7,130)$(498)$169$172Balance as of December 31, 2023$131130,741$1,245$241$(1,205)(6,661)$(359)$165$218Net earnings (losses)———(51)———1(50)Other comprehensive (loss) income——————204—204Dividends to Clorox stockholders ($1.20 per share declared)———(150)————(150)Dividends to noncontrolling interests———————(2)(2)Stock-based compensation——26—————26Other employee stock plan activities——(1)(6)16106——9Balance as of March 31, 2024$131130,741$1,270$34$(1,189)(6,555)$(155)$164$255Nine months ended March 31(Dollars in millions except per share data; shares in thousands)Common stockAdditional paid-in capitalRetained earningsTreasury stockAccumulatedothercomprehensivenet (loss) incomeNoncontrolling interestsTotal stockholders’ equityAmountSharesAmountSharesBalance as of June 30, 2022$131130,741$1,202$1,048$(1,346)(7,589)$(479)$173$729Net earnings (losses)———(27)———7(20)Other comprehensive (loss) income——————(19)—(19)Dividends to Clorox stockholders ($4.72 per share declared)———(587)————(587)Dividends to noncontrolling interests———————(11)(11)Stock-based compensation——60—————60Other employee stock plan activities——(30)(19)69459——20Balance as of March 31, 2023$131130,741$1,232$415$(1,277)(7,130)$(498)$169$172Balance as of June 30, 2023$131130,741$1,245$583$(1,246)(6,921)$(493)$168$388Net earnings———64———771Other comprehensive (loss) income——————338—338Dividends to Clorox stockholders ($4.80 per share declared)———(600)————(600)Dividends to noncontrolling interests———————(11)(11)Stock-based compensation——55—————55Other employee stock plan activities——(30)(13)57366——14Balance as of March 31, 2024$131130,741$1,270$34$(1,189)(6,555)$(155)$164$255





---




Three months ended March 31Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) incomeBalance as of December 31, 2022$(459)$107$(150)$(502)Other comprehensive (loss) income before reclassifications9(3)—6Amounts reclassified from Accumulated other comprehensive net (loss) income—(4)1(3)Income tax benefit (expense)1——1Net current period other comprehensive (loss) income10(7)14Balance as of March 31, 2023$(449)$100$(149)$(498)Balance as of December 31, 2023$(439)$90$(10)$(359)Other comprehensive (loss) income before reclassifications(16)2—(14)Amounts reclassified from Accumulated other comprehensive net (loss) income(1)223(2)—221Income tax benefit (expense), and other(1)(1)(1)(3)Net current period other comprehensive (loss) income206(1)(1)204Balance as of March 31, 2024$(233)$89$(11)$(155)Nine months ended March 31Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) incomeBalance as of June 30, 2022$(448)$121$(152)$(479)Other comprehensive (loss) income before reclassifications(2)(5)—(7)Amounts reclassified from Accumulated other comprehensive net (loss) income—(18)4(14)Income tax benefit (expense)12(1)2Net current period other comprehensive (loss) income(1)(21)3(19)Balance as of March 31, 2023$(449)$100$(149)$(498)Balance as of June 30, 2023$(445)$99$(147)$(493)Other comprehensive (loss) income before reclassifications(10)(4)4(10)Amounts reclassified from Accumulated other comprehensive net (loss) income(1) (2)223(6)175392Income tax benefit (expense), and other(1)—(43)(44)Net current period other comprehensive (loss) income212(10)136338Balance as of March 31, 2024$(233)$89$(11)$(155)



















---




EMPLOYEE BENEFIT PLANS


171 130 19








Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Interest cost$2$4$10$13Expected return on plan assets(1)—(3)(2)(8)Amortization of unrecognized items—337Curtailment gain——(6)—Settlement loss——178—Total$2$4$183$12


3.3


1


8 12







OTHER CONTINGENCIES AND GUARANTEES





28


12 30-year 28 30-year





---




10 24.3 30-year














18 0




SEGMENT RESULTS


four











---







Net salesThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Health and Wellness$609$647$1,833$1,881Household5265501,3531,435Lifestyle3153539471,005International310305891876Corporate and Other5460166173Total$1,814$1,915$5,190$5,370Segment adjusted EBITThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Health and Wellness$154$161$517$418Household7499162165Lifestyle6483192217International382710474Corporate and Other(70)(101)(238)(251)Total$260$269$737$623Interest income44219Interest expense(22)(24)(69)(69)Loss on divestiture(1)(240)—(240)—Pension settlement charge(2)——(171)—Cyberattack costs(3)(8)—(57)—VMS impairment(4)—(445)—(445)Streamlined operating model(5)(10)(21)(13)(44)Digital capabilities and productivity enhancements investment(6)(26)(28)(85)(73)Earnings (losses) before income taxes$(42)$(245)$123$1








8 57
 Three months endedNine months ended3/31/20243/31/2024Health and Wellness18%15%Household1211Lifestyle—11International—4Corporate and Other7059Total100%100%





---







445


10 13 21 44
 Three months endedNine months endedInception to date ended3/31/20243/31/20233/31/20243/31/20233/31/2024Health and Wellness4%7%4%6%5%Household—4—21Lifestyle—2—33International—21—1913Corporate and Other9666967078Total100%100%100%100%100%








25 26


Net salesThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Cleaning29%30%30%30%Professional Products5455Health and Wellness34%34%35%35%Bags and Wraps12121212Cat Litter8999Grilling9866Household29%29%27%27%Food10101011Natural Personal Care3444Water Filtration4444Lifestyle17%18%18%19%International17%16%17%16%Corporate and Other3%3%3%3%Total100%100%100%100%







---












































---













































---







Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet sales$1,814$1,915(5)%$5,190$5,370(3)%


Three months ended March 31, 2024Percentage change versus the year-ago periodReported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & Divestitures(1)Foreign Exchange ImpactPrice/Mix/ Other(2)Organic Sales Growth / (Decrease) (Non-GAAP)(3)Organic Volume(4)Health and Wellness(6)%(4)%—%—%(2)%(6)%(4)%Household(4)(3)——(1)(4)(3)Lifestyle(11)(9)——(2)(11)(9)International(4)21(2)(44)45483Total Company(5)(5)%(4)%—%(7)%6%2%(4)%Nine months ended March 31, 2024Percentage change versus the year-ago periodReported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & Divestitures(1)Foreign Exchange ImpactPrice/Mix/Other(2)Organic Sales Growth / (Decrease) (Non-GAAP)(3)Organic Volume(4)Health and Wellness(3)%(5)%—%—%2%(3)%(5)%Household(6)(9)——3(6)(9)Lifestyle(6)(7)——1(6)(7)International(4)2(2)(1)(27)3130(1)Total Company(5)(3)%(6)%—%(4)%7%1%(6)%


























---







Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeGross profit$766$800(4)%$2,164$2,0466%Gross margin42.2%41.8%41.7%38.1%











Three months ended% of Net Sales3/31/20243/31/2023% Change3/31/20243/31/2023Selling and administrative expenses$301$311(3)%16.6%16.2%Advertising costs215206411.910.8Research and development costs3235(9)1.81.8Nine months ended% of Net Sales3/31/20243/31/2023% Change3/31/20243/31/2023Selling and administrative expenses$899$8545%17.3%15.9%Advertising costs566523810.99.7Research and development costs93100(7)1.81.9

















---




Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Loss on divestiture$240$—$240$—Pension settlement charge——171—Goodwill, trademark and other asset impairments—445—445Interest expense22246969Other (income) expense, net(2)24354Effective tax rate on earnings (losses)(18.6)%14.7%41.9%1,813.5%



































---







Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeDiluted net earnings (losses) per share$(0.41)$(1.71)76%$0.52$(0.22)336%
















Net salesThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Health and Wellness$609$647$1,833$1,881Household5265501,3531,435Lifestyle3153539471,005International310305891876Corporate and Other5460166173Total$1,814$1,915$5,190$5,370 Segment adjusted EBIT(1)Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Health and Wellness$154$161$517$418Household7499162165Lifestyle6483192217International382710474Corporate and Other(70)(101)(238)(251)Total$260$269$737$623Interest income44219Interest expense(22)(24)(69)(69)Loss on divestiture(240)—(240)—Pension settlement charge——(171)—Cyberattack costs(8)—(57)—VMS impairment—(445)—(445)Streamlined operating model(10)(21)(13)(44)Digital capabilities and productivity enhancements investment(26)(28)(85)(73)Earnings (losses) before income taxes$(42)$(245)$123$1










---




Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet sales$609$647(6)%$1,833$1,881(3)%Segment adjusted EBIT154161(4)51741824










Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet sales$526$550(4)%$1,353$1,435(6)%Segment adjusted EBIT7499(25)162165(2)













Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet sales$315$353(11)%$947$1,005(6)%Segment adjusted EBIT6483(23)192217(12)
















---




Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet sales$310$3052%$891$8762%Segment adjusted EBIT3827411047441













---





















Three months endedNine months ended3/31/20243/31/2023% Change3/31/20243/31/2023% ChangeNet Sales$54$60(10)%$166$173(4)%Segment adjusted EBIT(70)(101)31(238)(251)5












Nine months ended3/31/20243/31/2023Net cash provided by operations$355$728Net cash used for investing activities(94)(142)Net cash used for financing activities(382)(526)

















---


















































Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Dividends per share declared$1.20$1.18$4.80$4.72Total dividends paid148146446437







---





























---













Reconciliation of earnings (losses) before income taxes to adjusted EBITThree months endedNine months ended3/31/20243/31/20233/31/20243/31/2023Earnings (losses) before income taxes$(42)$(245)$123$1Interest income(4)(4)(21)(9)Interest expense22246969Loss on divestiture(1)240—240—Pension settlement charge(2)——171—Cyberattack costs(3)8—57—VMS impairment(4)—445—445Streamlined operating model(5)10211344Digital capabilities and productivity enhancements investment(6)26288573Adjusted EBIT$260$269$737$623




















---













Three months endedNine months ended3/31/20243/31/20233/31/20243/31/2023External consulting fees(1)$19$22$65$58IT project personnel costs(2)2264Other(3)541411Total$26$28$85$73

















---







Three months ended March 31, 2024Percentage change versus the year-ago periodHealth and WellnessHouseholdLifestyleInternationalTotal Company(1)Net sales growth / (decrease) (GAAP)(6)%(4)%(11)%2%(5)%Add: Foreign Exchange———447Add/(Subtract): Divestitures / Acquisitions(2)———2—Organic sales growth / (decrease) (non-GAAP)(6)%(4)%(11)%48%2%Nine months ended March 31, 2024Percentage change versus the year-ago periodHealth and WellnessHouseholdLifestyleInternationalTotal Company(1)Net sales growth / (decrease) (GAAP)(3)%(6)%(6)%2%(3)%Add: Foreign Exchange———274Add/(Subtract): Divestitures / Acquisitions(2)———1—Organic sales growth / (decrease) (non-GAAP)(3)%(6)%(6)%30%1%






















---





























































---
















































---
































---


























[a][b][c][d]PeriodTotal Number ofShares PurchasedAverage Price Paidper Share(1)Total Number ofShares Purchased asPart of PubliclyAnnounced Plans orProgramsMaximum Number (orApproximate DollarValue) of Shares thatMay Yet Be PurchasedUnder the Plans orProgramsJanuary 1 to 31, 2024—$——$993 millionFebruary 1 to 29, 2024———$993 millionMarch 1 to 31, 2024———$993 millionTotal———










none










---










Exhibit NumberExhibit Description31.1Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.31.2Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.101.SCHXBRL Taxonomy Extension Schema Document.101.CALXBRL Taxonomy Extension Calculation Linkbase Document.101.DEFXBRL Taxonomy Extension Definition Linkbase Document.101.LABXBRL Taxonomy Extension Label Linkbase Document.101.PREXBRL Taxonomy Extension Presentation Linkbase Document.104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).










---







THE CLOROX COMPANY(Registrant)DATE: April 30, 2024BY/s/ Laura PeckLaura PeckVice President – Chief Accounting Officer and Corporate Controller